Announced Thu, 28 May · 20:05 IST

Schedule of Analyst/ Institutional Investor''s meet - as enclosed

Board & Shareholder Meetings View source PDF

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.7%1-day move
₹1159.10
prior close
₹1157.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6-0.4-0.5-0.4-5.7-7.0-6.9-11.4-10.5-11.9-3.5-4.7
Up moveDown movePending
AI summary

Strides Pharma Science has scheduled a series of Non-Deal Road Shows with institutional investors across four major US cities from June 2-5, 2026. The meetings will be held in-person (one-on-one format) in New York, Chicago, Salt Lake City, and Los Angeles. The Q4 FY26 earnings presentation, already shared with exchanges on May 18, 2026, will serve as the discussion document. This is a routine regulatory intimation under SEBI Listing Obligations Regulations, informing the exchanges about planned investor engagement activities.

Likely market impact

This indicates active investor relations and transparency, showing management's willingness to engage directly with institutional investors. The US-focused roadshow suggests continued efforts to attract international investor interest in the company.